Innoviva
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.About INVA
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.
INVA Key Statistics
Stock Snapshot
As of today, Innoviva(INVA) shares are valued at $20.76. The company's market cap stands at 1.31B, with a P/E ratio of 54.94.
As of 2025-11-06, Innoviva(INVA) stock has fluctuated between $18.85 and $20.90. The current price stands at $20.76, placing the stock +10.1% above today's low and -0.7% off the high.
The Innoviva(INVA)'s current trading volume is 1.13M, compared to an average daily volume of 660.55K.
In the last year, Innoviva(INVA) shares hit a 52-week high of $22.00 and a 52-week low of $16.52.
In the last year, Innoviva(INVA) shares hit a 52-week high of $22.00 and a 52-week low of $16.52.
INVA News
(RTTNews) - Innoviva, Inc. (INVA) reported earnings for its third quarter that Increased, from last year The company's bottom line totaled $89.91 million, or $...
